Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132470) titled 'Clinical Study on the Efficacy and Safety of Medical Recombinant Composite Protein Combined with Fractional CO2 Laser in the Treatment of Atrophic Acne Scars' on Sept. 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Atrophic acne scars
Intervention:
Control side:Matrix Control products
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-20
Target Sample Size: Control side:35;Test side:35;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=340...